PUBLIC CONTRACT · 2020
201001141 - Ano 2020 - CPA 2019/40
- Contract value
- €196,287.00
- Signed on
- 29 October 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7239152PUBLISHED SUBJECT
EMTRICITABINA+RILPIVIRINA+TENOFOVIR ALAFENAMIDA
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GILEAD SCIENCES LDA. · Tax ID 503604704
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €196,287.00
- Procedure base price
- €196,574.60
- Total effective price
- Not reported on Portal BASE
- Publication date
- 29 October 2020
- Award date
- 27 October 2020
- Signing date
- 29 October 2020
- Performance period
- 63 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33651400-2 - Antivíricos de uso sistémico
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4844444
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.